Boden WE - Search Results

1

Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.

Boden WE, Marzilli M, Crea F, Mancini GBJ, Weintraub WS, Taqueti VR, Pepine CJ, Escaned J, Al-Lamee R, Gowdak LHW, Berry C, Kaski JC; Chronic Myocardial Ischemic Syndromes Task Force. Boden WE, et al. J Am Coll Cardiol. 2023 Feb 7;81(5):505-514. doi: 10.1016/j.jacc.2022.08.814. J Am Coll Cardiol. 2023. PMID: 36725179 Free PMC article. Review.

2

Advisory group reports on silent myocardial ischemia, acute intervention after myocardial infarction, and postinfarction management.

Pepine CJ, Kern MJ, Boden WE. Pepine CJ, et al. Among authors: boden we. Am J Cardiol. 1992 Mar 6;69(7):41B-46B. doi: 10.1016/0002-9149(92)91349-9. Am J Cardiol. 1992. PMID: 1543142 Review.

3

Importance of early recurrent ischemia on one-year survival after non-Q-wave acute myocardial infarction. Diltiazem Reinfarction Study Research Group.

Boden WE, Gibson RS, Kleiger RE, Schechtman KB, Capone RJ, Schwartz DJ, Roberts R. Boden WE, et al. Am J Cardiol. 1989 Oct 1;64(12):799-801. doi: 10.1016/0002-9149(89)90768-6. Am J Cardiol. 1989. PMID: 2801533 No abstract available.

4

Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.

Boden WE, Scheldewaert R, Walters EG, Whitehead A, Coltart DJ, Santoni JP, Belgrave G, Starkey IR. Boden WE, et al. Am J Cardiol. 1995 Jun 1;75(16):1120-3. doi: 10.1016/s0002-9149(99)80742-5. Am J Cardiol. 1995. PMID: 7762497 Clinical Trial.

5

Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.

Ferry DR, O'Rourke RA, Blaustein AS, Crawford MH, Deedwania PC, Carson PE, Pepine CJ, Thomas RG, Hlatky MA, Leppo JA, Iwane MK, Kleiger RE, Zoble RG, Dai H, Chow BK, Lavori PW, Boden WE. Ferry DR, et al. Among authors: boden we. J Am Coll Cardiol. 1998 Feb;31(2):312-20. doi: 10.1016/s0735-1097(97)00486-5. J Am Coll Cardiol. 1998. PMID: 9462573 Free article. Clinical Trial.

6

Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.

Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ; Veterans Affairs Non-Q-Wave Infarction Stategies in-Hospital (VANQWISH) Trial Investigators. Kerensky RA, et al. Among authors: boden we. J Am Coll Cardiol. 2002 May 1;39(9):1456-63. doi: 10.1016/s0735-1097(02)01770-9. J Am Coll Cardiol. 2002. PMID: 11985907 Free article.

7

Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic intervention.

Boden WE, Pepine CJ. Boden WE, et al. J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):1S-6S. doi: 10.1016/s0735-1097(02)03017-6. J Am Coll Cardiol. 2003. PMID: 12644334 Free article. No abstract available.

8

Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy.

Danias PG, Papaioannou GI, Ahlberg AW, O'Sullivan DM, Mann A, Boden WE, Heller GV. Danias PG, et al. Among authors: boden we. Am J Cardiol. 2004 Jul 1;94(1):14-9. doi: 10.1016/j.amjcard.2004.03.022. Am J Cardiol. 2004. PMID: 15219501

9

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.

Boden WE, O'rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Weintraub WS; COURAGE trial coprincipal investigators and study coordinators. Boden WE, et al. Am Heart J. 2006 Jun;151(6):1173-9. doi: 10.1016/j.ahj.2005.08.015. Am Heart J. 2006. PMID: 16781214

10

Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.

Weintraub WS, Barnett P, Chen S, Hartigan P, Casperson P, O'Rourke R, Boden WE, Lewis C, Veledar E, Becker E, Culler S, Kolm P, Mahoney EM, Dunbar SB, Deaton C, O'Brien B, Goeree R, Blackhouse G, Nease R, Spertus J, Kaufman S, Teo K. Weintraub WS, et al. Among authors: boden we. Am Heart J. 2006 Jun;151(6):1180-5. doi: 10.1016/j.ahj.2005.07.035. Am Heart J. 2006. PMID: 16781215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page